Physicians' Perceptions of Shared Decision Making in Chronic Disease and Its Barriers and Facilitators - 24/03/16
Doi : 10.1016/j.jpeds.2015.12.071
Cassandra M. Dodds, MA 1, Maria T. Britto, MD, MPH 1, 2, 3, Lee A. Denson, MD 3, 4, Daniel J. Lovell, MD, MPH 3, 5, Shehzad Saeed, MD 3, 4, Ellen A. Lipstein, MD, MPH 1, 2, 3, ⁎ 
1 Center for Innovation in Chronic Disease Care, Division of Adolescent and Transition Medicine, Cincinnati Children's Hospital Medical Center, Cincinnati, OH
2 James M. Anderson Center for Health Systems Excellence, Cincinnati Children's Hospital Medical Center, Cincinnati, OH
3 University of Cincinnati College of Medicine, Cincinnati, OH
4 Division of Gastroenterology, Hepatology, and Nutrition, Department of Pediatrics, Cincinnati Children's Hospital Medical Center, Cincinnati, OH
5 Division of Rheumatology, Department of Pediatrics, Cincinnati Children's Hospital Medical Center, Cincinnati, OH
∗Reprint requests: Ellen A. Lipstein, MD, MPH, Division of Adolescent and Transition Medicine, Cincinnati Children's Hospital Medical Center, 3333 Burnet Ave, Cincinnati, OH, 45229.Division of Adolescent and Transition MedicineCincinnati Children's Hospital Medical Center3333 Burnet AveCincinnatiOH45229
Abstract |
This study assessed pediatric physicians' use of shared decision making (SDM) in 2 chronic conditions. Most physicians indicated that parent and adolescent trust and emotional readiness facilitated SDM, physicians' preferred approach to decision making. At the same time, they perceived few barriers, other than insurance limitations, to using SDM.
Le texte complet de cet article est disponible en PDF.Keyword : SDM, TNFαi
Plan
| Funded by the Eunice Kennedy Shriver National Institute of Child Health & Human Development (K23HD073149 [to E.L.]). L.D. serves on the advisory board of Avaxia Biologics, Inc. D.L. receives consulting fees from AstraZeneca, Jannsen, Bristol-Myers Squibb, Abbott, Pfizer, Hoffman La-Roche, Novartis, UBC, Horizon; serves on the speaker's bureaus for Abbott, Amgen, Genentech; and serves on the data safety and monitoring board of Forest Research. S.S. serves on the speaker's bureau for Abbvie, Inc. The other authors declare no conflicts of interest. |
© 2016
Elsevier Inc. Tous droits réservés.
Vol 171
P. 307 - avril 2016 Retour au numéro
Article précédent
- Enhanced Infrastructure for Optimizing the Design and Execution of Clinical Trials and Longitudinal Cohort Studies in the Era of Precision Medicine
- Neil A. Goldenberg, Stephen R. Daniels, Peter M. Mourani, Frances Hamblin, Angela Stowe, Sylvia Powell, Daniel E. Ford, Jonathan Ellen
- Effective Radiation Dose in a Skeletal Survey Performed for Suspected Child Abuse
- Rachel P. Berger, Ashok Panigrahy, Shawn Gottschalk, Michael Sheetz
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?